David Rose
Partner, King & Wood Mallesons
David Rose is head of the Intellectual Property Group and Co-Chair of the Life Sciences & Healthcare Group at King & Wood Mallesons LLP in London. He represents many leading intellectual property owners notably in the pharmaceutical, TMT and financial services industries. David routinely advises on issues relating to infringement / validity of patents and SPCs, together with advice on patent and SPC protection, ownership disputes, experimental use and the undertaking of experiments for regulatory purposes. Many of the cases that David has advised upon are part of multi-jurisdictional disputes.
David has acted in a number of high profile patent disputes including Warner-Lambert v Dr Reddy’s Laboratories, HTC v. Gemalto, ratiopharm v. Alza, Leo Pharma v. Sandoz, Arrow Generics v. Merck, Cairnstores v. Astra Zeneca and SKB v. Generics UK.
David is recommended as a leading patent and life sciences lawyer in Legal 500, Chambers, IAM Patent 1000, MIP, Who’s Who Legal and LMG Life Sciences Europe.